0001104659-23-003528.txt : 20230112 0001104659-23-003528.hdr.sgml : 20230112 20230112200032 ACCESSION NUMBER: 0001104659-23-003528 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230112 DATE AS OF CHANGE: 20230112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oliviero James F III CENTRAL INDEX KEY: 0001434718 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38128 FILM NUMBER: 23526940 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC. STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc. CENTRAL INDEX KEY: 0001651407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472568632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 95 SAWYER ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 95 SAWYER ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02453 5 1 tm233206-3_5.xml OWNERSHIP DOCUMENT X0306 5 2022-12-31 0 0 0 0001651407 Checkpoint Therapeutics, Inc. CKPT 0001434718 Oliviero James F III 95 SAWYER RD, SUITE 110 WALTHAM MA 02453 1 1 0 0 CEO, President and Director Common Stock 2022-09-26 5 G 0 60000 0 D 196199 D On September 26, 2022, shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust. Checkpoint Therapeutics, Inc. effected a reverse stock split on December 6, 2022. The reported number gives effect to this reverse stock split. Includes shares of restricted common stock, which vest over various time periods. /s/ James F. Oliviero, III 2023-01-12